Literature DB >> 16804429

Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis.

Dror S Shouval1, David Greenberg, Noga Givon-Lavi, Nurith Porat, Ron Dagan.   

Abstract

BACKGROUND: Recent studies have shown that some Streptococcus pneumoniae serotypes possess a higher potential to cause invasive disease than others. However, it is unknown whether disease potential for specific serotypes is similar for mucosal disease. Our objective was to assess the disease potential of individual S. pneumoniae serotypes causing invasive pneumococcal disease (IPD), acute otitis media (AOM) and acute conjunctivitis (AC) in children.
METHODS: Serotypes of pneumococcal isolates from children with IPD, AOM and AC were compared with those carried by healthy children aged <3 years. All children resided in the same area and were studied during the same period. Odds ratios for disease were calculated for each diagnosis following multivariate analysis, including gender, age, ethnic group, previous antibiotic treatment and year variability.
RESULTS: A total of 5,500 isolates were collected: 189 from blood or cerebrospinal fluid, 3,200 from middle ear fluid, 348 from conjunctiva and 1,763 from nasopharynx of healthy children. A significant positive association with IPD was demonstrated for serotypes 1, 5 and 12F; with AOM for serotypes 1, 3, 5, 12F, 19A and 19F; and with AC for serotype 3 and nontypeable S. pneumoniae. A significant negative association with IPD was demonstrated for nontypeable S. pneumoniae and with AOM for serotypes 6A, 6B, 15A and nontypeable S. pneumoniae.
CONCLUSIONS: Our results reflect the importance of the polysaccharide capsule in site-specific disease potential and provide useful information regarding disease potential of nonvaccine serotypes shown to be involved in carriage replacement after vaccination with the 7-valent conjugate vaccine.

Entities:  

Mesh:

Year:  2006        PMID: 16804429     DOI: 10.1097/01.inf.0000220231.79968.f6

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  41 in total

1.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Authors:  Raquel Sá-Leão; Francisco Pinto; Sandra Aguiar; Sónia Nunes; João A Carriço; Nelson Frazão; Natacha Gonçalves-Sousa; José Melo-Cristino; Hermínia de Lencastre; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

3.  Differential circulation of Streptococcus pneumoniae serotype 6C clones in two Israeli pediatric populations.

Authors:  Nurith Porat; In Ho Park; Moon H Nahm; Ron Dagan
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

4.  Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

Authors:  N Grall; O Hurmic; M Al Nakib; M Longo; C Poyart; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

5.  Clinical features and outcomes of serotype 19A invasive pneumococcal disease in Calgary, Alberta.

Authors:  Leah J Ricketson; Otto G Vanderkooi; Melissa L Wood; Jenine Leal; James D Kellner
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-03       Impact factor: 2.471

6.  Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing.

Authors:  Alexey V Rakov; Kimiko Ubukata; D Ashley Robinson
Journal:  Infect Genet Evol       Date:  2011-08-25       Impact factor: 3.342

7.  Noninvasive pneumococcal clones associated with antimicrobial nonsusceptibility isolated from children in the era of conjugate vaccines.

Authors:  Martha McElligott; Imelda Vickers; Mary Meehan; Mary Cafferkey; Robert Cunney; Hilary Humphreys
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

8.  Baseline epidemiology and genetic structure of Streptococcus pneumoniae serotype 6D in southern Israel prior to introduction of pneumococcal conjugate vaccines.

Authors:  Nurith Porat; Rachel Benisty; Ronit Trefler; Doreen Ozalvo; Noga Givon-Lavi; Ron Dagan
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

9.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

10.  Streptococcus pneumoniae serotype 3 among Costa Rican children with otitis media: clinical, epidemiological characteristics and antimicrobial resistance patterns.

Authors:  Arturo Abdelnour; Carolina Soley; Silvia Guevara; Nurith Porat; Ron Dagan; Adriano Arguedas
Journal:  BMC Pediatr       Date:  2009-08-14       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.